BioRestorative Therapies, Inc. (OTCMKTS:BRTXQ – Get Free Report)’s share price hit a new 52-week high during mid-day trading on Tuesday . The company traded as high as $1.54 and last traded at $1.50, with a volume of 11049 shares traded. The stock had previously closed at $1.51.
BioRestorative Therapies Stock Performance
The firm has a market cap of $2.46 billion, a price-to-earnings ratio of -1.41 and a beta of 102.36. The business’s 50-day moving average is $1.62 and its 200-day moving average is $1.60.
About BioRestorative Therapies
BioRestorative Therapies, Inc develops therapeutic products using cell and tissue protocols primarily involving adult stem cells. The company’s two core programs are related to the treatment of disc/spine disease and metabolic disorders. Its disc/spine program includes a lead cell therapy candidate, BRTX-100 is a product formulated from autologous (or a person's own) cultured mesenchymal stem cells collected from the patient's bone marrow and intended for the non-surgical treatment of painful lumbosacral disc disorders.
See Also
- Five stocks we like better than BioRestorative Therapies
- Do Real Estate Investment Trusts Deserve a Place in Your Portfolio?
- Cerence Up 155% in 2 Days: SoundHound AI’s Fierce Competitor
- Basic Materials Stocks Investing
- Why Warren Buffett Is Selling: A Look at His Latest Market Moves
- What is a Dividend King?
- Why Amazon Shares May Never Trade Below $200 Again
Receive News & Ratings for BioRestorative Therapies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BioRestorative Therapies and related companies with MarketBeat.com's FREE daily email newsletter.
